Taiwan's capacity of Biomedicine research has been well recognized - The MOST has created a new "Blue Sea"

Jul 23, 2020

In order to show the achievements of biomedical research in Taiwan's universities and to link up with domestic and foreign companies, the MOST has set up a special zone at the BIO Asia-Taiwan 2020. The exhibition features 14 Global Research & Industry Alliance (GLORIA) schools of Medical Tests, Medical Materials, Vaccines and Pharmaceutical Development, to show Medical and Biogenetic Technology combined with health databases, IoT, AI, and 5G, drawing a vision for the future of digital health technologies. 
 
At today's opening ceremony of the alliance, Minister Tsung-Tsong Wu stated that through this year's "Online + Live," the exhibition would enable international colleagues to also see the capacity of Taiwan's biomedical technology. On the first day of the exhibition, NTU and four other universities signed a total of NT$135 million worth of cooperation with renowned foreign and domestic companies, including: NTU and Cathay Financial Holdings, Tsing Hua University and AMED Biomedical, Central University and DSM, China Medical University and EverFortune.AI, and Chang Gung University and EZconn Corporation.
 
The MOST will continue to promote biomedical technology through industry-academia cooperation, and will actively assist different industries in finding research and development partners at universities and in meeting the forward-looking technology required in the industry, so that important research achievements in the domestic academic research can be effectively aligned with the market. At the same time, it is hoped that universities will pool their resources to make efforts to transform the industrialization platform of regional scientific research, give full play to regional integration forces, foster inter-school cross-regional cooperation, and cultivate higher-level doctoral personnel. In addition, with the "six core strategic industries," it is hoped that Taiwan will be a key player and partner in the future of global industries and scientific research.
 
The 14 universities, including National Taiwan University, National Taiwan Ocean University, Taipei Medical University, China Medical University, National Tsing Hua University, National Central University, National Taiwan Normal University, Chang Gung University, Far East University, National Cheng Kung University, National Chiao Tung University, National Yang-Ming University, National Chung Hsing University, Chung Yuan University, have jointly exhibited R&D achievements of biotechnology, pharmaceutical development, precision medicine, AI for medicine, novel materials for medicine, smart medical, genetic testing, sports science, agricultural biotechnology and AIoT solutions for epidemic prevention.